Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 1
Submit an article Journal homepage
65
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Adenovirus Infection of Primary Malignant Lymphoid Cells

Roger K. Strair The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08901, USA
,
Wendy Sheay The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08901, USA
,
Lauri Goodell Department of Pathology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ 08901, USA
,
Eileen White Department of Molecular Biology, Howard Hughes Medical Institute, Biochemistry Rutgers University, Piscataway, NJ, USA; Center for Advanced Biotechnology and Medicine, University of Medicine and Dentistry of New Jersey, Piscataway, NJ 08901, USA
,
Arnold B. Rabson Department of Pathology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ 08901, USA; Department of Molecular Biology, Howard Hughes Medical Institute, Biochemistry Rutgers University, Piscataway, NJ, USA; Center for Advanced Biotechnology and Medicine, University of Medicine and Dentistry of New Jersey, Piscataway, NJ 08901, USA; Department of Molecular Genetics and Microbiology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, NJ 08901, USA
&
Daniel J. Medina The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08901, USA
Pages 37-49 | Published online: 01 Jul 2009

  • Debbas, M. and White, E. (1993) "Wild-Type p53 mediates apoptosis by E1A, which is inhibited by E1B", Genes Dev. 7, 546-554.
  • Chinnadurai, G. (1998) "Control of apoptosis by human adenovirus genes", Sem. Virol. 8, 399-409.
  • Teodoro, J.G. and Branton, P.E. (1997) "Regulation of apoptosis by viral gene products", J. Virol. 71, 1739-1746.
  • White, E. (1995) "Regulation of p53-dependent apoptosis by E1A and E1B", Curr. Top. Microbiol. Immunol. 199, 33-58.
  • Shapiro, G.I. and Harper, J.W. (1999) "Anticancer drag targets: cell cycle and checkpoint control", J. Clin. Invest. 104, 1645-1653.
  • Evan, G. and Littlewood, T. (1998) "A matter of life and cell death", Science 281, 1317-1322.
  • Prendergast, G.C. (1999) "Mechanisms of apoptosis by c-myc", Oncogene 18, 2967-2987.
  • Grana, X., Garriga, J. and Mayol, X. (1998) "Role of the retinoblastoma protein family, pRb, pl07, and p130 in the negative control of cell growth", Oncogene 17, 3365-3383.
  • Giaccia, A.J. and Kastan, M.B. (1998) "The complexity of p53 modulation: emerging patterns from divergent signals", Genes Dev. 19, 2973-2983.
  • Bischoff, J.R., Kirn, D.H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., Nye, J.A., Sampson-Johannes, A., Fattaey, A. and McCormick, F. (1996) "An adenovirus mutant that replicates selectively in p53-deficient human tumor cells", Science 274, 373-376.
  • Neumanitis, J., Ganly, I., Khuri, F., Arsenau, J., Kuhn, J., McCarty, T., Landers, S., Maples, P., Romel, L., Randlev, B., Reid, T., Kaye, S. and Kirn, D. (2000) "Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55-kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II clinical trial", Cancer Res. 15, 6359-6366.
  • Hangaishi, A., Ogawa, S., Imamura, N., Miyawaki, S., Miyura, Y., Uike, N., Shimazaki, C., Emi, N., Takeyama, K., Hirosawa, S., Kamada, N., Kobayashi, Y., Takemoto, Y., Kitani, T., Yoyoma, K., Ohtake, S., Yazaki, Y., Ueda, R. and Hirai, H. (1996) 'Inactivation of multiple tumor suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies", Blood 87, 4949-4958.
  • Catovsky, D. (1997) "The search for genetic clues in chronic lymphocytic leukemia", Hematol. Cell Ther. 39, S5-S12, 7th International Workshop on chronic lymphocytic leukemia.
  • Moller, M.B., Ino, Y., Gerdes, A.M. and Skojdt (1999) "Aberrations of p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large cell lymphoma", Leukemia 13, 453-459.
  • Ichikawa, A., Kinoshita, T., Watanabe, T., Kato, H., Nagai, N., Tsushita, K., Saito, H. and Hotta, T. (1997) "Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma", N. Engl. J. Med. 337, 529-534.
  • Vanasse, G.J., Concannon, P. and Willerford, D.M. (1999) "Regulated genomic instability and neoplasia in the lymphoid lineage", Blood 94, 3997-4010.
  • Migliazza, A., Martinotti, S., Chen, W., Fusco, C., Ye, B.H., Knowles, D.M., Offit, K., Chaganti, R.S. and Dalla-Favera, R. (1995) "Frequent somatic hypermutation of the 5' non-coding region of the bcl 6 gene in B-cell lymphomas", Proc, Natl. Acad. Sci. USA 92, 12520-12524.
  • Gaidano, G. and Dalla-Favera, R. (1998) "The biology of high grade non-Hodgkin's lymphomas", In: Canellos, G.P., Lister, T.A. and Sklar, J.L., eds, The Lymphomas (WB Saunders), p 338.
  • Stilgenbauer, S., Schaffner, C., Litterst, A., Liebisch, P., Gilad, S., Bar-Shira, A., James, M.R., Lichter, P. and Dohner, H. (1997) "Biallelic mutations in the ATM gene in T-prolymphocytic leukemia", Nat. Med. 3, 1155-1159.
  • Stankovic, T., Weber, P., Stewart, G., Bedenham, T., Murray, J., Byrd, P.J., Moss, P.A. and Taylor, A.M. (1999) "Inactivation of ATM gene in B-cell chronic lymphocytic leukemia", Lancet 353, 26-29.
  • Ong, S.T. and LeBeau, M.M. (1998) "Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma", Sem. Oncol. 25, 447-459.
  • Houldsworth, J., Mathew, S., Rao, P.H., Dyomina, K., Louie, D.C., Parsa, N., Offit, K. and Chaganti, R.S. (1996) "REL protooncogene is frequently amplified in extranodal diffuse large cell lymphoma", Blood 87, 25-29.
  • Capello, D. and Gaidano, G. (2000)) "Molecular pathophysiology of indolent lymphoma", Haematologica 85, 195-201.
  • Scaffidi, C., Kirchoff, S., Krammer, P.H. and Peter, M.E. (1999) "Apoptosis signaling in lymphocytes", Curr. Opin. Immunol. 11, 277-285.
  • Fang, W., Weintraub, B.C., Dunlap, B., Garside, P., Pape, K.A., Jenkins, M.K., Goodnow, C.C., Mueller, D.L. and Behrens, T.W. (1998) "Self-reacting B-lymphocytes overexpressing Bcl-XL escape negative selection and are tolerized by clonal anergy and receptor editing", Immunity 9, 35-45.
  • Liu, Y.J., Mason, D.Y., Johnson, G.D., Abbot, S., Gregory, C.D., Hardie, D.L., Gordon, J. and MacLennan, I.C. (1991) "Germinal center cells express bcl-2 after activation by signals which prevent their entry into apoptosis", Eur. J. Immunol. 21, 1905-1910.
  • Billian, M., Mondiere, P., Bernard, M., Bella, C. and Defrance, T. (1997) "Antigen receptor induced apoptosis of human germinal center B-cells is targeted in a centrocytic subset", Eur. J. Immunol. 27, 405-414.
  • Campo, E., Raffeld, M. and Jaffe, E.S. (1999) "Mantle-cell lymphoma", Sem. Hematol. 36, 115-127.
  • de Boer, Schuuring, E., Dreef, E., Peters, G., Bartek, J., Kluin, P.M. and van Krieken, J.H. (1995) "Cyclin D1 analysis in the diagnosis of mantle cell lymphoma", Blood 86, 2715-2723.
  • Jenkins, T.D., Mueller, A., Odze, R., Shahsafaei, A., Zukerberg, L.R., Kent, R., Stoner, G.D. and Rustgi, A.K. (1999) "Cyclin D1 overexpression combined with N-nitrosomethylbenzamine increases dysplasia and cellular proliferation in murine esophageal squamous epithelium", Oncogene 18, 59-66.
  • Hinds, P.W., Dowdy, S.E., Eaton, E.N., Arnold, A. and Weinberg, R.A. (1994) "Function of a human cyclin as an oncogene", Proc. Natl. Acad. Sci. USA 91, 709-713.
  • Dyson, N. (1998) "The regulation of E2F by pRb-family members", Genes Dev. 12, 2245-2262.
  • Lai, R., Medeiros, L.J., Coupland, R., McCourty, A. and Brynes, R.K. (1998) "Immunohistochemical detection of E2F-1 in non-Hodgkin's lymphomas: a survey of 124 cases", Mod. Pathol. 11, 457-463.
  • Zukerberg, L.R., Benedict, W.F., Arnold, A., Dyson, N., Harlow, E. and Harris, N.L. (1996) "Expression of the retinoblastoma gene in low-grade B-cell lymphoma: relationship to cyclin D1", Blood 88, 268-276.
  • Jares, P., Campo, E., Pinyol, M., Bosch, F., Miquel, R., Fernandez, P.L., Sanchez-Beato, M., Soler, F., Perez-Losada, A., Nayach, I., Mallofre, C., Piris, M.A., Montserrat, E. and Cardesa, A. (1996) "Expression of retinoblastoma gene product in mantle cell lymphoma. Correlation with cyclin D1 mRNA levels and proliferative activity", Am. J. Pathol. 148, 1591-1600.
  • Dowdy, S.F., Hinds, P.W., Louie, K., Reed, S.I., Arnold, A. and Weinberg, R.A. (1993) "Physical interactions of the retinoblastoma protein with human D cyclins", Cell 73, 499-511.
  • Adnane, J., Shao, Z. and Robbins, P.D. (1999) "Cyclin D1 associates with the TBP-associated factor TAFII250 to regulate Sp1-mediated transcription", Oncogene 18, 239-247.
  • Bernards, R. (1999) "CDK-independent activities of D-type cyclins", Biochim. Biophys. Acta 1424, 17-22.
  • Inoue, K., Sherr, C.J. and Shapiro, L.H. (1998) "Regulation of the CD 13 aminopeptidase N gene by DMP1 a transcription factor antagonized by D-type cyclins", J. Biol. Chem. 273, 29188-29194.
  • Hirai, H. and Sherr, C.J. (1996) "Interaction of D-type cycling with a novel myb-like transcription factors DMP1", Mol. Cell. Biol. 16, 6457-6467.
  • Albanese, C., D'Amico, M., Reutens, A.T., Fu, M., Watanabe, G., Lee, R.J., Kitsis, R.N., Henglein, B., Avantaggiati, M., Somasundaram, K., Thimmapaya, B. and Pestell, R.G. (1999) "Activation of the cyclin D1 gene by E1A-associated p300 through AP-1 inhibits cellular apoptosis", J. Biol. Chem. 274, 34186-34195.
  • Inoue, K., Roussel, M.F. and Sherr, C.J. (1999) "Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1", Proc. Natl. Acad. Sci. 96, 3993-3997.
  • Inoue, K. and Sherr, C.J. (1998) "Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin dependent kinase-independent mechanism", Mol. Cell Biol. 18, 1590-1600.
  • Kamijo, T., Weber, J.D., Zambetti, G., Zindy, F., Roussel, M.F. and Sherr, C.J. (1998) "Functional and physical interactions of the ARF tumor suppressor with p53 and mdm2", Proc. Natl. Acad. Sci. 95, 8292-8297.
  • Zwicker, J., Brusselbach, S., Jooss, U., Sewing, A., Behn, M., Lucibello, F.C. and Muller, R. (1999) "Functional domains in cyclin D1: pRb kinase activity is not essential for transformation", Oncogene 18, 19-25.
  • Lowe, S. and Ruley, H.E. (1993) "Stabilization of the p53 tumor suppressor gene is induced by Adenovirus E1A and accompanies apoptosis", Genes Dev. 7, 535-545.
  • Teodoro, J.G., Shore, G.C. and Branton, P.E. (1995) "Adenovirus E1A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms", Oncogene 11, 467-474.
  • Chiou, S.K. and White, E. (1997) "p300 Binding by E1A cosegregates with p53 induction but is dispensable for apoptosis", J. Virol. 71, 3515-3525.
  • Samuelson, A.V. and Lowe, S. (1997) "Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins", Proc. Natl. Acad. Sci. 94, 12094-12099.
  • Querido, E., Teodoro, J.G. and Branton, P.E. (1997) "Accumulation of p53 induced by the Adenovirus E1A protein requires regions involved in the induction of DNA synthesis", J. Virol. 71, 3526-3533.
  • de Stanchina, E., McCurrach, M.E., Zindy, F., Shieh, S.Y., Ferbeyre, G., Samuelson, A.V., Prives, C., Roussel, M.F., Sherr, C.J. and Lowe, S.W. (1998) "E1A signalling to p53 involves die p19ARF tumor suppressor", Genes Dev. 12, 2434-2442.
  • Thomas, A. and White, E. (1998) "Suppression of the p300-Dependent mdm2 negative-feedback loop induces the p53 apoptotic function", Genes Dev. 12, 1975-1985.
  • White, E., Cipriani, R., Sabbatini, P. and Denton, A. (1991) "Adenovirus E1B 19-Kilodalton protein overcomes the cytotoxicity of E1A proteins", J. Virol. 65, 2968-2978.
  • Pilder, S., Logan, J. and Shenk, T. (1984) "Deletion of the gene encoding the adenovirus 5 early region 1B 21,000--molecular weight polypeptide leads to degradation of viral and host cell DNA", J. Virol. 52, 664-671.
  • White, E., Grodzicker, T. and Stillman, B. (1984) "Mutations in the gene encoding the adenovirus early region 1B 19,000 molecular weight tumor antigen cause degradation of chromosomal DNA", J. Virol. 52, 410-419.
  • Subramanian, T., Kuppuswamy, M., Gysbers, J., et al., (1984) "19-kDa tumor antigen coded by early region E1B of adenovirus 2 is required for efficient synthesis and for protection of viral DNA", J. Biol. Chem. 259, 11777-11783.
  • Rao, L., Debbas, M., Sabbatini, P., Hockenbery, D., Korsmeyer, S. and White, E. (1992) "The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19-kDa and Bcl-2 proteins" Proc. Natl. Acad. Sci. 89, 7742-7746.
  • Grossman, S.R., Perez, M., Kung, A.L., Joseph, M., Mansur, C., Xiao, Z.X., Kumar, S., Howley, P.M. and Livingston, D.M. (1998) "P300/MDM2 complexes participate in MDM2 mediated p53 degradation", Mol. Cell 2, 405-415.
  • Boyer, J., Rohleder, K. and Ketner, G. (1999) "Adenovirus E4 34K and E4 11K inhibit double strand break repair and are physically associated with the cellular DNA-dependent protein kinase", Virology 263, 307-312.
  • Konig, C., Roth, J. and Dobbelstein, M. (1999) "Adenovirus type 5 E4orf3 protein relieves p53 inhibition by E1B-55-kilodalton protein", J. Virol. 73, 2253-2262.
  • Boivin, D., Morrison, M.R., Marcellus, R.C., Querido, E. and Branton, P.E. (1999) "Analysis of synthesis, stability, phosphorylation and interacting polypeptides of the 34-kilodalton product of open reading frame 6 of the early region 4 protein of human adenovirus 5", J. Virol. 73, 1245-1253.
  • Steegenga, W.T., Riteco, N., Jochemsen, A.G., Fallaux, F.J. and Bos, J.L. (1998) "The large E1B protein together with E4orf6 protein target p53 for active degradation in adenovirus infected cells", Oncogene 16, 349-357.
  • Nevels, M., Tauber, B., Kremmer, E., Spruss, T., Wolf, H. and Dobner, T. (1999) 'Transforming potential of the adenovirus type 5 E4orf3 protein", J. Virol. 73, 1591-1600.
  • Dobbelstein, M., Roth, J., Kimberly, W.T., Levine, A.J. and Shenk, T. (1997) "Nuclear export of E1B-55 kda and E4-34 kDa adenoviral oncoproteins mediated by a rev-like signal", EMBO J. 16, 4276-4284.
  • Marcellus, R.C., Lavoie, J.N., Boivin, D., Shore, G.C., Ketner, G. and Branton, P.E. (1998) "The early region 4 orf protein of human adenovirus type 5 induces p53-independent cell death by apoptosis", J. Virol. 72, 7144-7153.
  • Shtrichman, R. and Kleinberger, T. (1998) "Adenovirus type 5 E4 open reading frame 4 induces apoptosis in transformed cells", J. Virol. 72, 2975-2982.
  • Lavoie, J.N., Nguyen, M., Marcellus, R.C., Branton, P.E. and Shore, G.C. (1998) "E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk", J. Cell. Biol. 140, 637-645.
  • Shtrichman, R., Sharf, R., Barr, H., Dobner, T. and Kleinberger, T. (1999) "Induction of apoptosis by adenovirus E4orf4 is specific to transformed cells and requires interaction with protein phosphatase 2A", Proc. Natl. Acad. Sci. 96, 10080-10085.
  • Dobner, T., Horikoshi, N., Rubenwolf, S. and Shenk, T. (1996) "Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor", Science 272, 1470-1473.
  • Goodrum, F.D. and Ornelles, D.A. (1997) "The early region 1B 55 kilodalton oncoprotein of adenovirus relieves growth restriction imposed on viral replication by the cell cycle", J. Virol. 71, 548-561.
  • Nevels, M., Spruss, T., Wolf, H. and Dobner, T. (1999) "The adenovirus E4orfb protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53", Oncogene 18, 9-17.
  • Boyd, J.M., Malstrom, S., Subramanian, T., Venkatesh, L.K., Schaeper, U., Elangovan, B., D'Sa-Eipper, C. and Chinnadurai, G. (1994) "Adenovirus E1B 19-kDa and Bcl-2 proteins interact with a common set of cellular proteins", Cell 79, 341-351.
  • Chiou, S.K., Tseng, C.C., Rao, L. and White, E. (1994) "Functional complementation of the adenovirus E1B 19-kilodalton protein with bcl-2 in the inhibition of apoptosis in infected cells", J. Virol. 68, 6553-6566.
  • Boyd, J.M., Gallo, G.J., Elangovan, B., Venkatesh, L.K., Schaeper, U., Elangovan, B., D'Sa-Eipper, C. and Chinnadurai, G. (1995) "BIK, a novel death inducing protein shares a distinct sequence motif with bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins", Oncogene 11, 1921-1928.
  • Farrow, S.N., While, J.H., Martinou, L. Raven, T., Pun, K.T., Grinham, C.J. and Brown, R. (1995) "Cloning of a bcl-2 homologue by interaction with adenovirus E1B-19K", Nature 374, 731-733.
  • Han, J., Sabbatini, P., Perez, D., D. Rao, L., Modha, D. and White, E. (1996) "The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein", Genes Dev. 10, 461-477.
  • Han, J., Sabbatini, P. and White, E. (1996) "Induction of apoptosis by human Nbk/Bik, a BH3 containing protein that interacts with E1B-19K", Mol. Cell Biol. 16, 5857-5864.
  • Sarnow, P., Ho, Y.S., Williams, J. and Levine, A.J. (1982) "Adenovirus E1B-58-kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54-kd cellular protein in transformed cells", Cell 28, 387-394.
  • Yew, P.R., Liu, X. and Berk, A.J. (1994) "Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53", Genes Dev. 8, 190-202.
  • Teodoro, J.G. and Branton, P.E. (1997) "Regulation of p53-dependent apoptosis, transcriptional repression and cell transformation by phosphorylation of the 55 kilodalton E1B protein of adenovirus 5", J. Virol. 71, 3620-3627.
  • Harris, N.L., Jaffee, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B. and Gatter, K.C. (1994) "A revised European-American classification of hematopoietic neoplasms: a proposal from the international lymphoma study group", Blood 84, 1361 -1392.
  • Dierlamm, J., Baens, M., Wlordaska, I., Stefanova-Ouzounova, M., Hernandez, J.M., Hossfeld, D.K., De Wolf-Peeters, C., Hagemeijer, A., Van den Berghe, H. and Marynen, P. (1999) "The apoptosis inhibitor gene AP12 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q2l;q21) associated with mucosa-associated lymphoid tissue lymphomas", Blood 93, 3601-3609.
  • Jones, N. and Shenk, T. (1979) "An Adenovirus Type 5 early gene function regulates expression of other viral genes", Proc. Natl. Acad. Sci. USA 76, 3665-3669.
  • Klessig, D.F., Brough, D.E. and Cleghon, V. (1984) "Introduction, stable integration, and controlled expression of a chimeric adenovirus gene whose product is toxic to the recipient human cell", Mol. Cell. Biol. 4, 1354-1362.
  • Mateo, V., Lagneaux, L., Bron, D., Biron, G., Armant, M., Delespesse, G. and Sarfati, M. (1999) "CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia", Nature Med. 5, 1277-1284.
  • Mengubas, K., Riordan, F.A., Bravery, C.A., Lewin, J., Owens, D.L., Mehta, A.B., Hoffbrand, A.V. and Wickremasinghe, R.G. (1999) "Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanism", Oncogene 18, 2499-2506.
  • Reed, J.C. (1998) "Bcl-2 family proteins", Oncogene 17, 3225-3236.
  • Wickremasinghe, R.G. and Hoffbrand, A.V. (1999) "Biochemical and genetic control of apoptosis relevance to normal hematopoiesis and hematologic malignancies", Blood 93, 3587-3600.
  • Medina, D.J., Sheay, W., Goodell, L., Kidd, P., Rabson, A.B. and Strair, R.K. (1999) "Adenovirus-mediated cytotoxicity of chronic lymphocytic leukemia cells", Blood 94, 3499-3508.
  • Deisseroth, A.B., Zu, Z., Claxton, D., Hanania, E.G., Fu, S., Ellerson, D., Goldberg, L., Thomas, M., Janicek, K., Anderson, W.F., et al., (1994) "Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML", Blood 83, 3068-3076.
  • Brenner, M.K., Rill, D.R., Moen, R.C., Krance, R.A., Mirro, J., Anderson, W.F. and Ihle, J.N. (1993) "Gene marking to trace origin of relapse after autologous bone marrow transplantation", Lancet 341, 85-86.
  • Gribben, J.G., Freedman, A.S., Neuberg, D., Roy, D.C., Blake, K.W., Woo, S.D., Grossbard, M.L., Rabinowe, S.N., Coral, F., Freeman, G.J., et al., (1991) "Immunologic purging of marrow assessed by PCR before autologaus bone marrow transplantation for B-cell lymphoma", N. Engl. J. Med. 325, 1525-1533.
  • Price, C.G.A., Meerabux, J., Murtaugh, S., Cotter, F.E., Rohatiner, A.Z., Young, B.D. and Lister, T.A. (1991) "Circulating cells carrying t(14:18) in long remission from follicular lymphoma", J. Clin. Oncol. 9, 1527-1532.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.